top of page
Atopic dermatitis is a common inflammatory skin disease that affects many of your patients every day. Saakshi Khattri, MD, answers your questions about the use of JAK inhibitors for managing AD.
Saakshi Khattri, MD - How do you advise patients about the safety of topical ruxolitinib?
Saakshi Khattri, MD - Do you use topical ruxolitinib as first line therapy for sensitive areas?
Saakshi Khattri, MD - Do you ever combine topical ruxolitinib with other systemic therapies?
Saakshi Khattri, MD - Do you do any lab monitoring in patients prescribed topical ruxolitinib?
bottom of page